Menu

Discovery of the Malaria Parasite, 1880

Most didn’t believe French doctor Charles Louis Alphonse Laveran when he said he’d spotted the causative agent of the disease—and that it was an animal.

Sep 1, 2017
Shawna Williams

Laveran’s illustration of the various stages of in the life cycle of malaria parasites and their telltale pigment (black dots), published in the bulletin of the Société Médicale des Hôpitaux de Paris in 1881. As Francis Cox of the London School of Hygiene and Tropical Medicine writes in a 2010 review article in Parasites and Vectors, Laveran “suggested a course of events that began with clear spots that grew, acquired pigment and filled the corpuscle which then burst coinciding with the fevers associated with malaria.” At bottom is a male gametocyte expelling flagella-like microgametes, described by Laveran as “filiform elements which move with great vivacity.” © PAUL FEARN/ALAMY STOCK PHOTOThe idea that bad air rising from swamps caused malaria had a good run: at least two and a half millennia, from the time of the ancient Greeks until the mid-19th century. But as Louis Pasteur and Robert Koch popularized the germ theory of infection in the late 1870s, scientists began searching for a bacterial species responsible for the disease. Two scientists even reported having found the culprit, dubbed Bacillus malariae, in the Pontine Marshes near Rome.

But in a military hospital in Algeria, French doctor Charles Louis Alphonse Laveran was taking a close look at a distinctive, granular pigment found in the spleens and other tissues of malaria victims and in the blood of infected people. In November 1880, he trained a light microscope with a maximum magnification of 400x on a drop of fresh blood from a malaria patient. Inside the red blood cells, he saw round, pigment-filled moving bodies with flagella-like protrusions.

Because bacterial flagella can’t be seen with a light microscope, “that really convinced him that he was looking at an animal instead of a bacterium or a fungus,” says Irwin Sherman, a professor emeritus at the University of California, Riverside. As Laveran watched, one of the moving bodies shed its wavy tails.

Given the limited power of his microscope, “it’s remarkable that the drawings that you see in Laveran’s paper are so essentially detailed,” says Sherman. “It’s testimony to his expertise as a microscopist.” Differential stains had not yet been invented, but Sherman says the “highly refractive” malaria pigment inside the protozoa would have been key to Laveran’s ability to detect them.

Laveran went on to examine the blood of hundreds of patients with and without malaria, and found the tiny organisms only in the malaria samples. But he faced an uphill battle in convincing other scientists that what he was seeing were not just decaying red blood cells, but protozoa, and that the single-celled organisms caused the disease. Ultimately, Laveran succeeded in persuading even Pasteur and Koch that his discovery was real, and in 1907 he was awarded a Nobel Prize for it.

Not all of Laveran’s views on malaria would catch on, however. He continued to insist, for example, that the disease was caused by only one protozoan species, long after evidence emerged that there were two. (It would ultimately turn out that there are four species of malaria protozoa.) He also disliked the term “malaria,” thought to be derived from the Italian term for “bad air,” because he considered it unscientific and superstitious, and instead referred to the disease by its alternative French name, “paludisme.” 

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!